<?xml version='1.0' encoding='utf-8'?>
<document id="20159881"><sentence text="Oral anticoagulation with coumarin derivatives and antiplatelet effects of clopidogrel."><entity charOffset="26-34" id="DDI-PubMed.20159881.s1.e0" text="coumarin" /><entity charOffset="75-86" id="DDI-PubMed.20159881.s1.e1" text="clopidogrel" /><pair ddi="false" e1="DDI-PubMed.20159881.s1.e0" e2="DDI-PubMed.20159881.s1.e0" /><pair ddi="false" e1="DDI-PubMed.20159881.s1.e0" e2="DDI-PubMed.20159881.s1.e1" /></sentence><sentence text="A relevant proportion of patients receiving aspirin and clopidogrel after percutaneous coronary intervention (PCI) also require oral anticoagulation with a coumarin derivative such as phenprocoumon"><entity charOffset="44-51" id="DDI-PubMed.20159881.s2.e0" text="aspirin" /><entity charOffset="56-67" id="DDI-PubMed.20159881.s2.e1" text="clopidogrel" /><entity charOffset="156-164" id="DDI-PubMed.20159881.s2.e2" text="coumarin" /><entity charOffset="184-197" id="DDI-PubMed.20159881.s2.e3" text="phenprocoumon" /><pair ddi="false" e1="DDI-PubMed.20159881.s2.e0" e2="DDI-PubMed.20159881.s2.e0" /><pair ddi="false" e1="DDI-PubMed.20159881.s2.e0" e2="DDI-PubMed.20159881.s2.e1" /><pair ddi="false" e1="DDI-PubMed.20159881.s2.e0" e2="DDI-PubMed.20159881.s2.e2" /><pair ddi="false" e1="DDI-PubMed.20159881.s2.e0" e2="DDI-PubMed.20159881.s2.e3" /><pair ddi="false" e1="DDI-PubMed.20159881.s2.e1" e2="DDI-PubMed.20159881.s2.e1" /><pair ddi="false" e1="DDI-PubMed.20159881.s2.e1" e2="DDI-PubMed.20159881.s2.e2" /><pair ddi="false" e1="DDI-PubMed.20159881.s2.e1" e2="DDI-PubMed.20159881.s2.e3" /><pair ddi="false" e1="DDI-PubMed.20159881.s2.e2" e2="DDI-PubMed.20159881.s2.e2" /><pair ddi="false" e1="DDI-PubMed.20159881.s2.e2" e2="DDI-PubMed.20159881.s2.e3" /></sentence><sentence text=" Both clopidogrel and phenprocoumon are metabolized by the hepatic cytochrome P450 system and a drug-drug interaction may exist at this level"><entity charOffset="6-17" id="DDI-PubMed.20159881.s3.e0" text="clopidogrel" /><entity charOffset="22-35" id="DDI-PubMed.20159881.s3.e1" text="phenprocoumon" /><pair ddi="false" e1="DDI-PubMed.20159881.s3.e0" e2="DDI-PubMed.20159881.s3.e0" /><pair ddi="false" e1="DDI-PubMed.20159881.s3.e0" e2="DDI-PubMed.20159881.s3.e1" /></sentence><sentence text=" The aim of this study was to investigate the impact of phenprocoumon on the antiplatelet effects of clopidogrel in patients with coronary artery disease"><entity charOffset="56-69" id="DDI-PubMed.20159881.s4.e0" text="phenprocoumon" /><entity charOffset="101-112" id="DDI-PubMed.20159881.s4.e1" text="clopidogrel" /><pair ddi="false" e1="DDI-PubMed.20159881.s4.e0" e2="DDI-PubMed.20159881.s4.e0" /><pair ddi="false" e1="DDI-PubMed.20159881.s4.e0" e2="DDI-PubMed.20159881.s4.e1" /></sentence><sentence text="" /><sentence text="Patients (n = 1223) eligible for this study were under dual maintenance antiplatelet treatment with aspirin and clopidogrel"><entity charOffset="100-107" id="DDI-PubMed.20159881.s6.e0" text="aspirin" /><entity charOffset="112-123" id="DDI-PubMed.20159881.s6.e1" text="clopidogrel" /><pair ddi="false" e1="DDI-PubMed.20159881.s6.e0" e2="DDI-PubMed.20159881.s6.e0" /><pair ddi="false" e1="DDI-PubMed.20159881.s6.e0" e2="DDI-PubMed.20159881.s6.e1" /></sentence><sentence text=" Adenosine diphosphate-induced platelet aggregation (in AU*min) was measured with multiple electrode platelet aggregometry on a Multiplate analyzer (Dynabyte, Munich, Germany)"><entity charOffset="1-22" id="DDI-PubMed.20159881.s7.e0" text="Adenosine diphosphate" /></sentence><sentence text=" From the entire study population, 124 (10" /><sentence text="1%) patients were under concomitant phenprocoumon treatment at the time point of platelet function testing" /><sentence text=" Platelet aggregation (median [interquartile range]) was significantly higher in patients with (n = 124) concomitant phenprocoumon treatment compared with patients without (n = 1099) phenprocoumon treatment (308 [190-493] AU*min vs" /><sentence text=" 224 [145-390] AU*min; P = 0" /><sentence text="0001, adjusted P = 0" /><sentence text="002)" /><sentence text="" /><sentence text="Phenprocoumon significantly attenuates the antiplatelet effects of clopidogrel"><entity charOffset="67-78" id="DDI-PubMed.20159881.s15.e0" text="clopidogrel" /></sentence><sentence text=" The impact of this interaction on the risk of thrombotic and bleeding events after PCI requires further investigations" /><sentence text="" /></document>